Efficacy of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease

Back

ESC2025 Premium Access

Efficacy of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease

Session: Drugs, devices, and diagnostics in heart failure

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Doctor D. Yoshiura (Tokyo, JP)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Daiki Yoshiura

Mitsui Memorial Hospital, Tokyo (Japan)

0 follower

7 more presentations in this session

Effects of beta-blockers on exercise capacity and hemodynamic response during CPET with echocardiography in heart failure with preserved ejection fraction

Speaker: Doctor S. Dhont (Genk, BE) Doctor P. Bertrand (Genk, BE)

Effects of sodium-glucose cotransporter-2 inhibitors on left ventricular-arterial coupling and myocardial extracellular volume in patients with type 2 diabetes mellitus and HFpEF

Speaker: Doctor A. Marathonitis (Athens, GR)

Finerenone-related risk of hypotension in patients with heart failure with mildly reduced or preserved ejection fraction

Speaker: Doctor A. Foa' (Bologna, IT)

Hemodynamic effects of lactate infusion in chronic heart failure patients

Speaker: Doctor N. Abild Jespersen (Aarhus N, DK)

Resynchronization reduces arginase activity in red blood cells of heart failure patients with dyssynchrony

Speaker: Doctor K. Ljung (Stockholm, SE)

Access the full session

Drugs, devices, and diagnostics in heart failure

Speakers: Doctor D. Yoshiura, Doctor S. Dhont, Doctor P. Bertrand, Doctor A. Marathonitis, Doctor A. Foa'...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources